MedTrace Logo

China Diabetes Cardiovascular Initiative

NCT05037058 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 9600

Last updated 2021-09-08

No results posted yet for this study

Summary

As a collaborative project between American Heart Association, Chinese Society of Cardiology, American Diabetes Association and Chinese Diabetes Society, the China Diabetes Cardiovascular Initiative aims to enhance the attention and awareness of cardiovascular health care professionals (HCPs) in the managements of cardiovascular diseases and diabetes, to reduce diabetes-related complication and minimize adverse events in patients with cardiovascular disease, and to reduce the risk of cardiovascular morbidity and mortality in diabetic patients.

Conditions

Interventions

OTHER

Quality improvement activities

Quality improvement activities

Sponsors & Collaborators

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05037058 on ClinicalTrials.gov